CHRS logo
CHRS

Coherus Oncology Inc

Biotechnology

Coherus Oncology Inc (CHRS) Earnings

Last reported
April 30, 2026
EPS estimate
-$0.28
EPS actual
Revenue est.
$14.6M
Revenue actual